Emerging data suggest this peptide, a dual stimulator targeting both incretin and another hormone, appears to provide a promising advancement for weight management . Early clinical investigations have demonstrated impressive reductions in visceral fat , conceivably exceeding other weight-loss treatments. However , additional study is needed to full